Suppr超能文献

多粘菌素:抗菌活性、药敏试验以及由质粒或染色体编码的耐药机制

Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

作者信息

Poirel Laurent, Jayol Aurélie, Nordmann Patrice

机构信息

Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland

French INSERM European Unit, University of Fribourg (LEA-IAME), Fribourg, Switzerland.

出版信息

Clin Microbiol Rev. 2017 Apr;30(2):557-596. doi: 10.1128/CMR.00064-16.

Abstract

Polymyxins are well-established antibiotics that have recently regained significant interest as a consequence of the increasing incidence of infections due to multidrug-resistant Gram-negative bacteria. Colistin and polymyxin B are being seriously reconsidered as last-resort antibiotics in many areas where multidrug resistance is observed in clinical medicine. In parallel, the heavy use of polymyxins in veterinary medicine is currently being reconsidered due to increased reports of polymyxin-resistant bacteria. Susceptibility testing is challenging with polymyxins, and currently available techniques are presented here. Genotypic and phenotypic methods that provide relevant information for diagnostic laboratories are presented. This review also presents recent works in relation to recently identified mechanisms of polymyxin resistance, including chromosomally encoded resistance traits as well as the recently identified plasmid-encoded polymyxin resistance determinant MCR-1. Epidemiological features summarizing the current knowledge in that field are presented.

摘要

多粘菌素是公认的抗生素,由于耐多药革兰氏阴性菌引起的感染发病率不断上升,最近重新引起了人们的极大关注。在临床医学中观察到多药耐药性的许多地区,黏菌素和多粘菌素B正被重新认真考虑作为最后的抗生素选择。与此同时,由于多粘菌素耐药菌的报告增多,目前正在重新考虑在兽医学中大量使用多粘菌素的情况。多粘菌素的药敏试验具有挑战性,本文介绍了目前可用的技术。介绍了为诊断实验室提供相关信息的基因型和表型方法。本综述还介绍了与最近发现的多粘菌素耐药机制相关的最新研究成果,包括染色体编码的耐药特征以及最近发现的质粒编码的多粘菌素耐药决定因子MCR-1。本文还介绍了总结该领域当前知识的流行病学特征。

相似文献

2
Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01390-18. Print 2019 Apr.
3
Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
J Antibiot (Tokyo). 2017 Apr;70(4):386-394. doi: 10.1038/ja.2016.146. Epub 2017 Jan 11.
4
Resistance to polymyxins in Gram-negative organisms.
Int J Antimicrob Agents. 2017 May;49(5):526-535. doi: 10.1016/j.ijantimicag.2016.11.029. Epub 2017 Feb 3.
5
Molecular mechanisms of polymyxin resistance: knowns and unknowns.
Int J Antimicrob Agents. 2016 Dec;48(6):583-591. doi: 10.1016/j.ijantimicag.2016.06.023. Epub 2016 Aug 4.
6
The rise and spread of plasmid-mediated polymyxin resistance.
Crit Rev Microbiol. 2019 Mar;45(2):131-161. doi: 10.1080/1040841X.2018.1492902. Epub 2019 May 23.
7
Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
Int J Antimicrob Agents. 2018 Apr;51(4):586-593. doi: 10.1016/j.ijantimicag.2017.12.016. Epub 2017 Dec 27.
8
Polymyxin antibiotics for gram-negative infections.
Am J Health Syst Pharm. 2007 Apr 15;64(8):819-26. doi: 10.2146/ajhp060473.
9
Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update.
J Glob Antimicrob Resist. 2018 Mar;12:124-136. doi: 10.1016/j.jgar.2017.09.011. Epub 2017 Sep 28.
10
Mechanisms of Polymyxin Resistance.
Adv Exp Med Biol. 2019;1145:55-71. doi: 10.1007/978-3-030-16373-0_5.

引用本文的文献

1
Colistimethate sodium is efficacious and safe for the management of sepsis in hematological diseases patients: a retrospective study in China.
Front Cell Infect Microbiol. 2025 Aug 13;15:1613414. doi: 10.3389/fcimb.2025.1613414. eCollection 2025.
2
Colistin-Resistant Isolated from Houseflies and Feces of Cattle and Pigs at a Slaughterhouse in Lima, Peru.
Antibiotics (Basel). 2025 Aug 10;14(8):818. doi: 10.3390/antibiotics14080818.
5
Recent advances in the understanding, detection and therapeutic targeting of bacterial recalcitrance.
BMC Microbiol. 2025 Aug 8;25(1):488. doi: 10.1186/s12866-025-04210-1.
7
Halicin: A New Approach to Antibacterial Therapy, a Promising Avenue for the Post-Antibiotic Era.
Antibiotics (Basel). 2025 Jul 11;14(7):698. doi: 10.3390/antibiotics14070698.

本文引用的文献

1
Emergence of Colistin Resistance Gene mcr-1 in Cronobacter sakazakii Producing NDM-9 and in Escherichia coli from the Same Animal.
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01444-16. Print 2017 Feb.
2
Coproduction of MCR-1 and NDM-1 by Colistin-Resistant Escherichia coli Isolated from a Healthy Individual.
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01962-16. Print 2017 Jan.
3
MCR-1 confers cross-resistance to lysozyme.
Lancet Infect Dis. 2016 Nov;16(11):1226-1227. doi: 10.1016/S1473-3099(16)30395-4.
5
China bans colistin as a feed additive for animals.
Lancet Infect Dis. 2016 Oct;16(10):1102-1103. doi: 10.1016/S1473-3099(16)30329-2. Epub 2016 Sep 19.
6
Kluyvera ascorbata Strain from Hospital Sewage Carrying the mcr-1 Colistin Resistance Gene.
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7498-7501. doi: 10.1128/AAC.01165-16. Print 2016 Dec.
7
Structure of the catalytic domain of the colistin resistance enzyme MCR-1.
BMC Biol. 2016 Sep 21;14(1):81. doi: 10.1186/s12915-016-0303-0.
8
A Model for Transposition of the Colistin Resistance Gene mcr-1 by ISApl1.
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6973-6976. doi: 10.1128/AAC.01457-16. Print 2016 Nov.
9
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验